{
    "symbol": "IKT",
    "quarter": 4,
    "year": 2022,
    "date": "2023-04-03 13:29:06",
    "content": " Grant revenue was $0.1 million for the year ended December 31, 2022, compared to $3.1 million for fiscal year 2021. Research and development expenses were $12 million for the year ended December 31, 2022, compared to $11.4 million for the year ended 2021. Selling, general and administrative expenses were $6.2 million for the year ended December 31, 2022, compared to $6.5 million for the prior fiscal year. For the year ended December 31, 2022, we reported a net loss of approximately $18.1 million or $0.72 per share compared to a net loss of $14.8 million or $0.81 per share in the year ended December 31, 2021."
}